AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $88.27
- 52-wk high
- $98.15
- High
- $88.82
- 52-wk low
- $73.22
- Low
- $87.77
- Prev close
- $88.03
- Mkt cap
- $69.19B
- P/E
- 34.6x
- Volume
- 3.59M
- Fwd P/E
- 21.5x
- Beta
- 0.32
- Div yield
- 2.38%
- P/S
- 3.3x
- P/B
- 296.9x
- Profit margin
- +9.7%
- Op margin
- +21.0%
- ROE
- +267.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 4.2% above what analysts expected.
Earnings per share
$0.95 expected
Revenue
No comparable estimate
FY2026 guidance
$2.00 to $6.00
No comparable estimate
Reports Oct 30, 2026, in 47 days
EPS expected
$0.89 to $0.96
Revenue expected
13 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.13B | $5.23B | $5.32B | $5.36B |
| Cost of what it sold | $2.08B | $2.08B | $2.10B | $2.06B |
| Gross profit | $3.05B | $3.15B | $3.23B | $3.30B |
| What it spent | ||||
| Sales and admin | $1.32B | $1.98B | $2.08B | $2.13B |
| Other operating costs | $634.0M | $90.0M | — | $150.0M |
| Total operating expenses | $1.95B | $2.07B | $2.08B | $2.28B |
| What was left | ||||
| Operating profit | $1.10B | $1.08B | $1.16B | $1.02B |
| Interest on debt | $67.0M | $64.0M | $62.0M | $62.0M |
| Profit before tax | $992.0M | $107.0M | $892.0M | $950.0M |
| Tax | $226.0M | $112.0M | $211.0M | $231.0M |
| Net profit | $735.0M | -$37.0M | $646.0M | $693.0M |
| EBITDA | $1.22B | $344.0M | $1.11B | $1.17B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
The Manufacturers Life Insurance Company Lowers Stake in Colgate-Palmolive Company $CL
NeutralSep 12Colgate-Palmolive explores sale of select personal care brands: Report
Leans bullishSep 12An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
NeutralSep 12Colgate Weighs Sale Of Mass-Market Personal Care Brands In $1 Billion Deal
Leans bullishSep 11Colgate-Palmolive Stock (CL) Dips on Plan to Sell Personal Care Brands
Leans bearishSep 11Colgate-Palmolive exploring $1B divestment of select brands, Reuters reports
Leans bullishSep 11Colgate-Palmolive exploring $1B divestment of select brands, Reuters reports
Leans bullishSep 11Exclusive-Colgate-Palmolive seeks to divest some personal care brands, sources say
Leans bullishSep 11
Macro
21 macro signals shaping CL right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results